期刊文献+

卡维地洛对慢性心力衰竭患者心功能的影响 被引量:3

The Effect of Carvedilol on Cardiac Function of the Chronic Heart Failure
在线阅读 下载PDF
导出
摘要 目的探讨卡维地洛治疗慢性心力衰竭(心衰)患者对心功能的影响。方法56例慢性心衰患者随机分为卡维地洛组30例和常规治疗组26例。常规组应用血管紧张素转换酶抑制剂、利尿剂和洋地黄制剂。卡维地洛组在此其础上加用卡维地洛。结果治疗后卡维地洛组临床改善总有效率86.6%,显著高于常规治疗组65.4%,P<0.05。左室射血分数为(50.21±7.91)%,显著高于常规治疗组(41.70±5.45)%,P<0.05。结论在常规抗心衰治疗基础上加用卡维地洛,能明显改善心功能,提高左室射血分数。 OBJECTIVE To evaluate the effect of Carvedilol on cardiac function of the chronic heart failure (CHF). METHODS 56 patients with CHF were divided randomly into two groups, carvedilol treatment group (30 cases) and generally treatment group (26 cases), In generally treatment group, the cases were treated with ACE inhibitor , digoxin and diuretic. In carvedilol treatment group, the cases were treated with carvedilol on the basis of above generally treatment group. RESULTS In carvedilol treatment group , the total improvement rate ( 86.6% ) was significantly bighter than that in generally treatment group ( 65.4% ) ( P 〈 0.05 ), and the LVEF (left ventficular EF) (50.21 ±7.91 )% was significantly highter than that in generally treatment group (41.70 ± 5. 45) % (P 〈 0.05 ). CONCLUSION In carvedilol treatment group, the cardiac function may be improved remarkably, and also in LVEF.
出处 《中国现代应用药学》 CAS CSCD 北大核心 2007年第1期81-82,共2页 Chinese Journal of Modern Applied Pharmacy
关键词 卡维地洛 心力衰竭 慢性 Β受体阻滞剂 carvedilol chronic Heart failure β-receptor antagonists
  • 相关文献

参考文献3

二级参考文献9

  • 1Wallukat G, Fu ML, Maggnusson Y, et al. Agonistic effects of anti-peptide autibodies and autoantibodies directed against adrenergic and cholinergic rcceptor:absence of desensitization. Blood Pressure, 1996,5(Suppl 3):31-36.
  • 2Podlowski S, Luther HP, Morwinski R, et al. Agonistic anti-β1- adrenergic rcceptor autoantibodies from cardiomyopathy patients reduce the β1- adrenergic rcceptor expression in neonatal rat cardiomyocytes. Circulation,1998,98:2470-2476.
  • 3Luther HP, Homuth V, Wallukat G, et al. α1-adrenergic receptor antibodies in patients with primary hypertension. Hypertension,1997,29:678-682.
  • 4Nakajima T, Ma J, Zida H, et al. Inhibitory effects of carvedilol on calcium channels in vascular smooth muscle cell. Jpn Heart J, 2003,44:963-978.
  • 5Yao A, Kohmoto O, Oyama T, et al. Characteristic effects of alpha1-beta1,2-adrenergic blocking agent, carvedilol, on [Ca2+] I in ventricular myocytes compared with those of timolol and atenolol. Circ J,2003,67:83-90.
  • 6Liu X, Callaerts VZ, Evans KL,et al. Chronic infusion of beta-adrenoceptor antagonist and inverse agonists decrease elevated protein kinase a activity in transgenic mice with cardiac-specific overexpression of human beta2-adrenoceptor. J Cardiovasc Pharmacol, 2002,40:448-455.
  • 7张麟,刘慧荣,赵荣瑞,张健,惠汝太,刘力生.扩张型心肌病抗心肌β_1与M_2受体自身抗体的初步研究[J].中华心血管病杂志,1998,26(1):15-17. 被引量:46
  • 8张麟,胡大一,史旭波,李静,曾文军,徐立,崔亮.心脏β_1和M_2受体自身抗体与心力衰竭的研究[J].中华内科杂志,2001,40(7):445-447. 被引量:38
  • 9张麟,吴雅峰,缪国斌,张磊,刘瑞红,刘秀兰.心力衰竭患者与心脏β_2、α_1肾上腺素能受体和血管紧张素Ⅱ1型受体的自身抗体[J].中华心血管病杂志,2003,31(1):17-20. 被引量:26

共引文献188

同被引文献28

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部